Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 14.08%36.42B | 3.60%6.68B | 20.36%13.84B | 7.71%9.05B | 22.86%6.85B | 8.35%31.92B | 13.00%6.45B | 10.68%11.5B | 15.88%8.41B | -8.87%5.57B |
Cost of revenue | 12.11%28.06B | 1.16%5.4B | 19.12%10.65B | 8.84%6.88B | 15.84%5.12B | 8.53%25.02B | 23.16%5.34B | 7.42%8.94B | 13.24%6.32B | -8.18%4.42B |
Gross profit | 21.21%8.36B | 15.33%1.28B | 24.68%3.18B | 4.27%2.17B | 49.81%1.73B | 7.71%6.9B | -19.11%1.11B | 23.85%2.55B | 24.70%2.08B | -11.41%1.15B |
Operating expense | 5.16%4.9B | 16.02%1.26B | 24.02%1.52B | -12.45%1.07B | -6.65%1.05B | 6.61%4.66B | -1.71%1.08B | 0.63%1.22B | 17.02%1.22B | 12.14%1.13B |
Staff costs | 8.64%3.25B | 11.87%736.56M | 21.41%1.14B | -5.73%694.76M | 3.34%678.05M | 3.00%2.99B | -9.74%658.43M | 10.09%936.35M | 13.21%736.96M | -2.05%656.16M |
Depreciation and amortization | 4.31%63.27M | 12.87%17.48M | 2.11%15.91M | 0.94%15.19M | 1.02%14.69M | 9.99%60.65M | -23.37%15.49M | 31.91%15.58M | 28.83%15.05M | 27.03%14.54M |
-Depreciation | 4.31%63.27M | 12.87%17.48M | 2.11%15.91M | 0.94%15.19M | 1.02%14.69M | 9.99%60.65M | -23.37%15.49M | 31.91%15.58M | 28.83%15.05M | 27.03%14.54M |
Rent and land expenses | -1.24%351.75M | -4.29%84.92M | -1.98%86.97M | -1.87%87.8M | 3.17%92.06M | -13.68%356.16M | -13.02%88.73M | -18.40%88.73M | -12.60%89.47M | -10.30%89.23M |
Other operating expenses | -1.30%1.24B | 30.30%418.52M | 52.02%276.62M | -28.55%270.91M | -27.03%270.17M | 25.26%1.25B | 27.97%321.21M | -25.39%181.96M | 36.37%379.13M | 63.06%370.23M |
Operating profit | 54.57%3.47B | -14.40%21.57M | 25.28%1.67B | 27.93%1.1B | 2,880.21%671.95M | 10.08%2.24B | -90.61%25.19M | 57.15%1.33B | 37.45%862.41M | -92.31%22.55M |
Net non-operating interest income (expenses) | -2.24%305K | 34.33%270K | -83.00%17K | 0 | 63.64%18K | 58.38%312K | 12.29%201K | 1,011.11%100K | 0 | 22.22%11K |
Non-operating interest income | -2.24%305K | 34.33%270K | -83.00%17K | --0 | 63.64%18K | 58.38%312K | 12.29%201K | 1,011.11%100K | --0 | 22.22%11K |
Net investment income | 18.50%117.19M | 7.92%70.24M | 4M | 31.18%35.16M | 11.10%7.8M | 47.63%98.9M | 83.37%65.08M | 0 | 6.93%26.8M | 9.06%7.02M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | -445K | 0 | 0 | ||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | ||||||||||
Other non-operating income (expenses) | -61.75%6.31M | 109.14%847K | 187.69%5.56M | -53.30%2.49M | -129.22%-2.58M | 194.77%16.5M | 26.56%405K | 14.18%1.93M | 104.61%5.33M | 799.29%8.84M |
Income before tax | 52.26%3.59B | 2.24%92.92M | 25.81%1.68B | 27.61%1.14B | 1,662.88%677.18M | 38.92%2.36B | -70.15%90.88M | 57.08%1.33B | 268.70%894.09M | -87.23%38.41M |
Income tax | 31.25%1.06B | -205.11%-97.5M | 34.26%554.19M | 33.51%377.54M | 1,050.74%226.28M | 50.57%807.99M | -6.58%92.76M | 52.72%412.78M | 263.63%282.79M | -77.97%19.66M |
Net income | 63.22%2.53B | 10,228.19%190.41M | 22.02%1.12B | 24.89%763.44M | 2,305.02%450.89M | 33.53%1.55B | -100.92%-1.88M | 59.11%920.9M | 271.09%611.31M | -91.13%18.75M |
Net income continuous operations | 63.22%2.53B | 10,222.86%190.41M | 22.02%1.12B | 24.89%763.43M | 2,304.90%450.9M | 33.53%1.55B | -100.92%-1.88M | 59.11%920.9M | 271.09%611.31M | -91.13%18.75M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 63.22%2.53B | 10,228.19%190.41M | 22.02%1.12B | 24.89%763.44M | 2,305.02%450.89M | 33.53%1.55B | -100.92%-1.88M | 59.11%920.9M | 271.09%611.31M | -91.13%18.75M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 63.22%2.53B | 10,228.19%190.41M | 22.02%1.12B | 24.89%763.44M | 2,305.02%450.89M | 33.53%1.55B | -100.92%-1.88M | 59.11%920.9M | 271.09%611.31M | -91.13%18.75M |
Gross dividend payment | ||||||||||
Basic earnings per share | 62.93%748.01 | 8,360.29%56.17 | 21.78%332.35 | 24.63%225.96 | 2,301.62%133.53 | 33.28%459.1 | -101.12%-0.68 | 58.82%272.91 | 270.55%181.31 | -91.15%5.56 |
Diluted earnings per share | 62.93%748.01 | 8,360.29%56.17 | 21.73%332.212 | 24.48%225.6994 | 2,301.62%133.53 | 33.28%459.1 | -101.12%-0.68 | 58.82%272.91 | 270.55%181.31 | -91.15%5.56 |
Dividend per share | 87.50%300 | 87.50%300 | 0 | 0 | 0 | 45.45%160 | 45.45%160 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |